KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exelixis (EXEL) Non-Current Assets: 2010-2025

Historic Non-Current Assets for Exelixis (EXEL) over the last 15 years, with Oct 2025 value amounting to $1.4 billion.

  • Exelixis' Non-Current Assets rose 0.76% to $1.4 billion in Q4 2025 from the same period last year, while for Oct 2025 it was $1.4 billion, marking a year-over-year increase of 0.76%. This contributed to the annual value of $1.5 billion for FY2025, which is 8.88% down from last year.
  • Latest data reveals that Exelixis reported Non-Current Assets of $1.4 billion as of Q4 2025, which was down 5.08% from $1.5 billion recorded in Q3 2025.
  • Exelixis' Non-Current Assets' 5-year high stood at $1.6 billion during Q4 2023, with a 5-year trough of $691.9 million in Q1 2021.
  • Its 3-year average for Non-Current Assets is $1.5 billion, with a median of $1.5 billion in 2025.
  • Its Non-Current Assets has fluctuated over the past 5 years, first declined by 20.87% in 2021, then skyrocketed by 85.89% in 2022.
  • Exelixis' Non-Current Assets (Quarterly) stood at $781.5 million in 2021, then skyrocketed by 85.89% to $1.5 billion in 2022, then grew by 11.82% to $1.6 billion in 2023, then declined by 8.02% to $1.4 billion in 2024, then climbed by 0.76% to $1.4 billion in 2025.
  • Its last three reported values are $1.4 billion in Q4 2025, $1.5 billion for Q3 2025, and $1.4 billion during Q2 2025.